- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02839395
The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health
The human eye has a dual role, which is reflected by the various photo-receptors used for vision of images and colors ,Image forming photoreceptors (IFP) and for entrainment of our "Biological clock" located in the hypothalamus through the retinal ganglions known as non-image forming photoreceptors (NIFP). The recently discovered new photo-pigment melanopsin which is sensitive to short wavelength (SWL) illumination exists in the-NIFP. The axons of the NIFP form a special nerve known as the Retino-hypothalamic-tract (RHT) that transfers the SWL signal to the biological clock resulting in suppression of pineal melatonin (MLT) production. This is the basic mechanism by which environmental light/dark cycles entrain the biological clock and transfer the message to organs, tissues and cell.
The American Medical Association (AMA) issued a resolution in 2012 stating that light at night constitutes environmental pollution because it violates the daily cycles, including the waking and sleeping cycles, and suppresses the secretion of melatonin from the pineal gland at night. Results of other studies have shown that exposure to artificial light at night (ALAN) and mainly those emerging from SWL sources suppresses MLT-produced in the pineal gland. Computers, tablets, TVs, and smart-phones screens emit SWL illumination, during the day and night hours, whether as active or passive users. The results of previous studies show that, exposure to SWL-ALAN illumination suppresses MLT-secretion and disrupts sleep patterns. In order to understand better the effect of SWL-exposure emerging from screens on human behavior and health, the investigators will study the effects of SWL-exposure on the structure and quality of sleep, cognitive functioning in Continous Performance Test (CPT III), emotional state, and physiological, variables (melatonin secretion levels and body temperature) that were not tested in previous studies.
Study Overview
Status
Intervention / Treatment
Detailed Description
The investigators will examine whether there is a difference between one-time and multiple exposures to computer screen lighting (350 lux). The investigators hypothesize that multiple and continuous exposure will have a more significant detrimental effect on the quality of sleep and consequently on performance, emotional, and physiological indicators, than one-time exposure to screen light.
Procedure:
On the base-line, first and fifth night of the study, at the end of two hours of exposure to screen light, the subject will be connected to the sleep test system by a skilled technician. On all other nights (nights 2-4), exposure to computer light only, will be conducted and at the end of the exposure the subject will be asked to go to sleep. During the entire experimental period the subject will wear an Actigraph watch to ensure regular sleeping hours. In addition, subjects will be asked not to expose themselves to a computer/tablet/smartphone screen from 20:00 h to wake up.
An Actigraph will monitor their sleep during the week of the experiment. The subject will be invited to attend the Sleep Institute at 21:00 h. The subject will be asked to enter the test room, which will be dark, and sit in front of a computer screen for two hours at a distance of about 60 cm from the screen and perform the on-screen tasks between the hours of 21:00 and 23:00 h. The tasks will include: reading and writing Microsoft Word documents, , and answering questions dealing with a document read and, solving verbal and arithmetic problems, while attempting to accomplish the task correctly and in the quickest time possible. The subject will be told that the purpose of the study is to examine the effect of the content of the tasks on the quality of sleep. During exposure, the subject will be allowed to eat and drink, but do not go to the bathroom. At the end of two hours of exposure to screen light, the subject will be connected to the sleep test system by a skilled technician. Body temperature and 6-hydroxymelatonin sulfate(6-SMT) in the urine will be measured using the on-set and off-set methods three times, at 21:00, 23:00 h, and close to the falling asleep time. Three measurements will be taken after awakening. After the sleep test system is installed, the subject will be asked to go to sleep and in the morning will be woken at his/her average waking time. After the examinee has been woken and has provided a urine sample and body temperature measurement, the sleep test system will be removed and the examinees will be given 30 minutes to organize him/herself, before performing the following tasks to assess his/her degree of fatigue and sleepiness: Continous Performance Test (CPT-III), the Brief Symptoms Inevntory (BSI) emotional questionnaire, and the Epworth Sleepiness Scale (ESS) and Karolinska Sleepiness Scale (KSS) questionnaire.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 20-45,
- healthy
- No history of visual disturbances
- No history of sleep disorders
Exclusion Criteria:
- score more then 5 in the Pittsburgh Questionnaire (PSQI).
- Subjects with a-typicality deviation in the HORNE - OSTBERG sleep-wakefulness cycle questionnaire.
- One of the Eye problems: field of vision, color blindness, or impaired functioning of the pupil in reaction to light.
- Subjects who did shiftwork three months before the experiment
- Subjects that taking sleeping medications in general and melatonin in particular
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: base line
First night is the base line- no exposure to computer screen illumination.
|
the subject will sited in a dim light room.
No screen light illumination.
|
|
Experimental: Acute
Second night is the acute exposure to computer screen illumination.
|
The subject will be sited in front of computer screen light illumination for 2 hours.
|
|
Experimental: Chronic
Chronic is the effect after five nights of exposure to computer screen light illumination.
|
The subject will be sited in front of computer screen light illumination for 2 hours for 5 consecutive days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
body temperature
Time Frame: 12 hours
|
body temperature in celsius degree.physiological
marker
|
12 hours
|
|
Melatonin secretion
Time Frame: 12 hours
|
Melatonin -Sulfate Urine ELISA 6-SMT ng/ml.
physiological marker
|
12 hours
|
|
sleepiness
Time Frame: 1 day
|
ESS questionnaire score- number
|
1 day
|
|
BSI Questionnaire
Time Frame: 1 day
|
assess the subject's emotional state- number
|
1 day
|
|
Subjective sleepiness
Time Frame: 1 day
|
KSS questionnaire-number
|
1 day
|
|
attention
Time Frame: 1 hour
|
a neuropsychological computerized attention and concentration test, designed to test attentional functions.
number
|
1 hour
|
|
total Sleep time
Time Frame: 1 night
|
total sleep time in minutes.
physiological marker
|
1 night
|
|
Sleep efficiency
Time Frame: 1 night
|
percentage of sleep efficiency- physiological marker
|
1 night
|
|
sleep latency to sleep stage1
Time Frame: 1 night
|
time in minute to sleep stage 1. physiological marker
|
1 night
|
|
sleep latency to sleep stage2
Time Frame: 1 night
|
time in minute to sleep stage 2. physiological marker
|
1 night
|
|
wake %TIB
Time Frame: 1 night
|
percentage of wake from Time in bed.
physiological marker
|
1 night
|
|
REM %TIB
Time Frame: 1 night
|
percentage of REM from Time in bed.
physiological marker
|
1 night
|
|
staege1%TIB
Time Frame: 1 night
|
percentage of sleep stage1 from Time in bed.
physiological marker
|
1 night
|
|
stage2%TIB
Time Frame: 1 night
|
percentage of sleep stage2 from Time in bed.physiological marker
|
1 night
|
|
stage4%TIB
Time Frame: 1 night
|
percentage of sleep stage4 from Time in bed.physiological marker
|
1 night
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0005-16-ASMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
Clinical Trials on No intervention- base line
-
Riphah International UniversityCompleted
-
University Health Network, TorontoUnknownTraining | EducationCanada
-
University of Illinois at ChicagoWashington University School of Medicine; University of PittsburghActive, not recruitingHypertension | Obesity | Metabolic Syndrome | Dyslipidemias | Pre-diabetes | Type2diabetes | CARDIOMETABOLIC CONDITIONSUnited States
-
University of TorontoNot yet recruitingDental Caries | Dental Plaque | Periodontal Disease
-
University of CopenhagenCompleted
-
Menoufia UniversityMansoura UniversityNot yet recruiting
-
Copenhagen Academy for Medical Education and SimulationTechnical University of DenmarkNot yet recruiting
-
Taipei Medical UniversityTaipei Medical University Hospital; Taipei Medical University Shuang Ho Hospital and other collaboratorsCompletedHemodialysis ComplicationTaiwan
-
National Taiwan Normal UniversityRecruiting
-
Universidad Rey Juan CarlosRecruiting